期刊文献+

缺氧对滋养细胞sFlt-1及VEGF基因及蛋白表达的影响 被引量:11

Effect of Hypoxia on mRNA and Protein Expression of sFlt-1 and VEGF in Cytotrophoblast Cells of Human
原文传递
导出
摘要 目的:探讨缺氧对滋养细胞可溶性血管内皮生长因子受体1(soluble fims-like tyrosine kinase receptor-1,sFlt-1)及血管内皮生长因子(vascular epithelial growth factor,VEGF)表达的影响。方法:CoCl2诱导人早孕绒毛滋养细胞系TEV-1化学缺氧,分别于0h、24h、48h、72h、96h、120h用Real-time RT-PCR法检测滋养细胞中sFlt-1及VEGF mRNA表达,ELISA法检测细胞培养上清液中sFlt-1及VEGF蛋白表达。结果:滋养细胞缺氧72h后,胞质内可见明显空泡。滋养细胞sFlt-1mRNA及蛋白表达随缺氧时间的延长逐渐升高,且与缺氧72h、96h、120h间差异有显著性(P<0.05)。而滋养细胞VEGF mRNA及蛋白表达随缺氧时间的延长呈现出先上升后下降的趋势,并于缺氧48h升高达到峰值(P<0.05)。结论:不同的缺氧时间对滋养细胞VEGF及sFlt-1表达具有重要的调控作用。慢性缺氧可能导致滋养细胞sFlt-1及VEGF表达平衡失调,从而参与子痫前期的发生、发展。 Objective:To investigate the effect of hypoxia on mRNA and protein expressions of soluble fimslike tyrosine kinase receptor-1(sFlt-1) and vascular epithelial growth factor(VEGF) in human first-trimester extravillous trophoblast cell line TEV-1.Methods:TEV-1 was treated with CoCl2 for 0 h,24 h,48 h,72 h,96 h,120 h,respectively.The mRNA expressions of sFlt-1 and VEGF were detected by real-time RT-PCR,and their protein levels were detected by ELISA kit.Results:Cytoplasmic vacuoles in TEV-1 was observed after 72 h of hypoxic treatment.The sFlt-1 expression showed a time-dependent increase in TEV-1(P0.05 for 72 h,96 h and 120 h treatment),while the VEGF expression was increased during first 48 h,then decreased over time(P0.05).Conclusion:Various hypoxia time may play an important role in expression of VEGF and sFlt-1 in TEV-1.Chronic hypoxia can lead to disequilibrium of VEGF and sFlt-1,which may contribute to the development of preeclampsia.
出处 《生殖与避孕》 CAS CSCD 北大核心 2010年第5期300-304,共5页 Reproduction and Contraception
关键词 子痫前期 缺氧 滋养细胞 可溶性血管内皮生长因子受体1(sFlt-1) 血管内皮生长因子(VEGF) preeclampsia hypoxia trophoblast cells soluble fims-like tyrosine kinase receptor 1(sFlt-1) vascular epithelial growth factor(VEGF)
  • 相关文献

参考文献16

  • 1Koga K, Osuga Y, Yoshino O, et al. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J Clin Endocrinol Metab, 2003, 88(5):2348-51.
  • 2Korean J. Increased sFlt-1 to PIGF ratio in women who subsequently develop preeclampsia. Med Sci, 2007, 22 (5):873-7.
  • 3Chaiworapongsa T, Romero R, Espinoza J, et al. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. Am J Obstet Gynecol, 2004, 190 (6): 1541-50.
  • 4Polliotti BM, Fry AG, Sailer DN, et al. Secondtrimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia. Obstet Gynecol, 2003, 101(6): 1266-74.
  • 5Tsatsaris V, Goffin F, Munaut C, et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients:pathophysiological consequences. J Clin Endocrinol Metab, 2003, 88(11):5555-63.
  • 6周琼,刘海意,曾万江,龚洵,吴媛媛,乔福元.缺氧调控滋养细胞和内皮细胞sFlt-1差异表达的研究[J].现代妇产科进展,2009,18(11):844-846. 被引量:5
  • 7Feng HC, Choy MY, Deng W, et al. Establishment and characterization of a human first-trimester extravillous trophoblast cell line (TEV-1). J Soc Gynecol Investig, 2005, 12(4):21-32.
  • 8Lockwood C J, Toti P, Arcuri F, et al. Thrombin regulates soluble fms-like tyrosine kinase-1 (sFlt-1) expression in first trimester decidua:implications for preeclampsia. Int J Fertil Womens Med, 2007, 52(2-3):59-67.
  • 9Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocrine Rev, 2004, 25(4):581-611.
  • 10Roeckl W, Hecht D, Sztajer H, et al. Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2. Exp Cell Res, 1998, 241(1):161-70.

二级参考文献19

  • 1傅勤,林建华.血管内皮生长因子在子痫前期发病机制中的研究[J].国外医学(妇产科学分册),2006,33(1):23-26. 被引量:5
  • 2Redman CW, Sargent IL. Latest advances in understanding preeclampsia [ J]. Science ,2005,308 : 1592-1594.
  • 3McKeeman GC, ArdiU JE, Caldwell CM, et al. Soluble vascular endothelial growth factor receptor-1 ( sFh-1 ) is increased throughout gestation in patients who have preeclampsia develop[ J]. Am J Obstet Gynecol,2004,191 : 1240-1246.
  • 4Feng HC, Choy MY, Deng W, et al. Establishment and characterization of a human first-trimester extravillous trophoblast cell line ( TEV-1 ) [ J ]. J Soc Gynecol Investig,2005,12 : e21-e32.
  • 5Shibuya M. Structure and dual function of vascular endothelial growth factor receptor-1 ( Fh-1 ) [ J ]. Int J Biochem Cell Biol,200,1,33:409-420.
  • 6Nakatsukasa H, Masuyama H, Takamoto N, et al. Circulating leptin and angiogenic factors in preeclampsia patients [ J]. Endocr J,2008,55:565-573.
  • 7Nagamatsu T, Fujii T, Kusumi M, et al. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia [ J ]. Endocrinology ,2004,145:4838-4845.
  • 8Karumanchi SA, Bdolah Y. Hypoxia and sFlt-1 in preeclampsia : the" Chicken-and-Egg" question [ J ]. Endocrinology, 2004,145 : 4835 -4837.
  • 9Ahmad S, Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia [ J ]. Circ Res,2004,95 : 884-891.
  • 10Kim SY, Ryu HM, Yang JH, et al. Increased sFlt-1 to PIGF ratio in women who subsequently develop preeclampsia[ J ]. J Korean Med Sci ,2007,22:873-877.

共引文献12

同被引文献176

引证文献11

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部